ENTX
Entera Bio Ltd

7,115
Mkt Cap
$88.96M
Volume
117,607.00
52W High
$3.22
52W Low
$1.50
PE Ratio
-7.93
ENTX Fundamentals
Price
$1.94
Prev Close
$2.00
Open
$1.96
50D MA
$2.37
Beta
0.51
Avg. Volume
111,234.26
EPS (Annual)
-$0.2534
P/B
5.82
Rev/Employee
$9,050.00
Loading...
Loading...
News
all
press releases
Miranda Jayne Toledano Acquires 11,000 Shares of Entera Bio (NASDAQ:ENTX) Stock
Entera Bio Ltd. (NASDAQ:ENTX - Get Free Report) CEO Miranda Jayne Toledano bought 11,000 shares of the company's stock in a transaction on Monday, December 29th. The stock was purchased at an average...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Entera Bio (NASDAQ:ENTX) CEO Miranda Jayne Toledano Acquires 11,000 Shares
Entera Bio Ltd. (NASDAQ:ENTX - Get Free Report) CEO Miranda Jayne Toledano acquired 11,000 shares of the company's stock in a transaction that occurred on Monday, December 29th. The shares were...
MarketBeat·2d ago
News Placeholder
Entera Bio (NASDAQ:ENTX) Rating Increased to Sell at Wall Street Zen
Wall Street Zen upgraded shares of Entera Bio to a "sell" rating in a research report on Saturday...
MarketBeat·5d ago
News Placeholder
HC Wainwright Increases Earnings Estimates for Entera Bio
Entera Bio Ltd. (NASDAQ:ENTX - Free Report) - Stock analysts at HC Wainwright boosted their FY2025 earnings per share estimates for shares of Entera Bio in a research note issued to investors on...
MarketBeat·7d ago
News Placeholder
Entera Bio (NASDAQ:ENTX) Trading Down 0.9% - Here's What Happened
Entera Bio (NASDAQ:ENTX) Trading Down 0.9% - What's Next...
MarketBeat·23d ago
News Placeholder
Entera Bio (NASDAQ:ENTX) Releases Earnings Results, Beats Expectations By $0.02 EPS
Entera Bio (NASDAQ:ENTX - Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates...
MarketBeat·2mo ago
News Placeholder
Entera Bio (ENTX) Expected to Announce Quarterly Earnings on Friday
Entera Bio (NASDAQ:ENTX) will be releasing its Q3 2025 earnings before the market opens on Friday, November 14. (View Earnings Report at...
MarketBeat·2mo ago
News Placeholder
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
ENTX posts positive PK data for its first oral GLP-2 therapy, signaling a potential breakthrough in short bowel syndrome treatment.
Zacks·4mo ago
<
...
1
>

Latest ENTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.